HaemTRIAL

Haematology Academic Research Organisation

[Marc Carrier @MarcCarrier1]

Have you ever wondered about the long-term risk of recurrence in patients with isolated SSPE?
New data suggest the risk may not exceed the threshold for extended duration anticoagulation. Case by case decision is needed.
👉https://t.co/PMJqCIXUXJ

@ThrombosisCan @canvector @JRand083 @ThrombosisRese1 @OttMethodsCentr
#VTE #PulmonaryEmbolism #MedTwitter

[Marc Carrier @MarcCarrier1]

Prof. @isabellemahe1 presents API-CAT at #ACC2025, published in @NEJM Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in patients with cancer.
https://t.co/vmDS2Ap7Uk

[Richard Buka 💙 @richardbuka]

Very pleased to be involved with this project that is the first step on the ladder to interventional studies that can improve the experience of women who develop VTE and need anticoagulation.

DON'T STOP COC IN WOMEN WITH ACUTE VTE ON ANTICOAGULATION!

[HaemTRIAL @HaemTRIAL]

So right. Whilst AI is inevitable in healthcare…we first need to get the basics right. Computers that work and primary and secondary care databases that talk to each other are necessary bedrocks.

[Kamran Abbasi @KamranAbbasi]

“No tech entrepreneur, no early adopter of AI, wants to talk about solving life’s boring problems. The tech dream is transformational and aspirational.”

Serendipitously timed for a global IT outage, here I argue in praise of boring AI @bmj_latest https://t.co/bJ2cP9eMxE

[Adam Grant @AdamMGrant]

We don't need to debate whether it's better to be a generalist or a specialist. The world needs both.

Specialists excel at zooming in. They see the details to deepen our knowledge.

Generalists excel at zooming out. They see around corners to broaden our view.

[HaemTRIAL @HaemTRIAL]

@bmj_latest So much evidence behind such a simple and safe intervention. Thank you for writing this Ian Roberts and @CHToh1. All haematologists should be advocates of TxA with surgical colleagues. Saddened that even with such great evidence, influencing change can be so slow.

[HaemTRIAL @HaemTRIAL]

@HaemSTAR_UK @PipNicolson @richardbuka

[HaemTRIAL @HaemTRIAL]

Are you a clinician who sees patients with secondary polycythaemia?

Are you frustrated by the lack of an evidence base for treating these patients?

Does your practise differ from your colleagues when treating these patients?

[HaemTRIAL @HaemTRIAL]

To help and express your interest in taking part– please give us 15 min of your time to fill out this simple 3-part survey.

https://t.co/mjGU0sUi6b

[Michael Makris @ProfMakris]

Article published in @RPTHjournal challenges the hypothesis that long covid is due to microclots. https://t.co/o2AOnPwJ8G #longcovid #covid19

[HaemTRIAL @HaemTRIAL]

https://t.co/2pWtn0Fvcs
Yassi et al. Lancet Neurology 2024. Behind a paywall and I can't see how the study was powered. Headline results: Tranexamic Acid doesn't prevent haematoma expansion / improve functional status or mortality after ICH. But very small study with v wide CIs.

[HaemTRIAL @HaemTRIAL]

@Ed_Pinches @unibirmingham @traceychan_1 Very good prospects for the future @traceychan_1!

[HaemTRIAL @HaemTRIAL]

@Ed_Pinches @AidanHaslam valuable work @AidanHaslam. Congratulations on getting the funding!

[HaemTRIAL @HaemTRIAL]

Very exciting discussions with potential industry partners today. So encouraged.

[Pip Nicolson @PipNicolson]

Getting excited about seeing @HaemSTAR_UK #RAPIDO data at #BSH2024…2 hours to go

[HaemTRIAL @HaemTRIAL]

@PipNicolson is having some exciting conversations with a clinical trials unit this week about finding a physical home for @HaemTRIAL